|

Simvastatin’s Efficacy in Treating Critically Ill COVID-19 Patientsc

ByThe Short Paper

Simvastatin in Critically Ill Patients with Covid-19 This study evaluated the effectiveness of simvastatin (a cholesterol-lowering medication) in treating critically ill COVID-19 patients. The trial involved 2684 patients and aimed to determine if simvastatin could increase the number of days free from respiratory and cardiovascular support. The results showed that simvastatin did not meet the…

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

ByThe Short Paper

Nirmatrelvir is a medication used to treat COVID-19. However, researchers were previously uncertain about how the virus could develop resistance to it. Recent findings have revealed that the virus can undergo two distinct changes to resist the medication. Some of these changes hinder the medicine’s effectiveness, while others make the virus more resilient. These combined…